Clinical Trial Update: A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical study evaluating universal CAR-T cells in patients with relapsed/refractory B-cell acute lymphoblastic leukemia, which is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Universal CAR-T cell

Snippet

Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine | Conditions: B-cell Acute Lymphoblastic Leukemia | Phase 1 | Status: NOT_YET_RECRUITING